Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

FDA Spells Out Who Can Use Rosiglitazone
Posted: Sunday, February 13, 2011
Rosiglitazone label updated to include elevated risk of cardiovascular events.

New Once Daily Insulin Degludec Reduces Hypoglycemia
Posted: Sunday, February 13, 2011
In Type 1 diabetes patients, insulin degludec -- an ultra-long-acting basal insulin -- controlled blood sugar levels as well as insulin glargine but with less hypoglycemia.

Aspirin for Primary Prevention in Diabetes
Posted: Sunday, February 06, 2011
When should aspirin be considered for the prevention of complications.

Insulin Detemir Combo with Sitagliptin and Metformin Efficacy & Safety
Posted: Sunday, February 06, 2011
Detemir plus sitagliptin more effective than sitagliptin with metformin with or without a sulfonylurea.

A Systematic Review of Newer Drugs for Glucose Control
Posted: Sunday, February 06, 2011
The National Institute for Health and Clinical Excellence (NICE) issued an updated Guideline for newer drugs for the management of all aspects of Type 2 diabetes. The guidelines review the newer agents from four classes with a cost analysis.

For Those 60 Percent of Type 2 Patients Who Are Not in Control
Posted: Saturday, January 29, 2011
Consider a GLP-1 plus a long-acting insulin.

Why Don't People Take Their Insulin as Prescribed?
Posted: Sunday, January 23, 2011
Risk factors differed between Type 1 and Type 2 diabetic patients, with diet nonadherence more prominent in Type 1 diabetes.

Race/Ethnicity Plays A Role in the Efficacy of Insulin Regimens
Posted: Sunday, January 23, 2011
Latino/Hispanic, Asian, and African-descent patients with Type 2 diabetes show different metabolic responses to insulin therapy, dependent in part on insulin type and regimen intensity.

FDA Still Inconclusive about Lantus Cancer Risk
Posted: Sunday, January 23, 2011
Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn't decided whether the concern is justified.

Birch Bark Ingredient Has Metabolic Benefits
Posted: Wednesday, January 19, 2011
In mice, a compound known as betulin lowered cholesterol, helped prevent diet-induced obesity and improved insulin sensitivity.

Page 11 of 94
 |<   <<   <  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement